SCHEMBL6629071

SCHEMBL6629071

O=C(NC1CCCCC1)NC1CCC(=O)N2CCC(C(=O)N[C@@H](Cc3ccccc3)C(=O)COC(=O)c3c(Cl)cccc3Cl)CN2C1=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.44
CASP6 P55212 2/20 0.44
CASP8 Q14790 2/20 0.44
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.39
MME P08473 2/20 0.38
ACE P12821 2/20 0.38
ITGA4 P13612 2/20 0.38
ITGB1 P05556 1/20 0.38
ITGB7 P26010 1/20 0.38
LCK P06239 1/20 0.37
CAPN1 P07384 3/20 0.37
KDM4E B2RXH2 1/20 0.37
CASP1 P29466 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6629068 1.00 CASP3 (0.44) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6629364 0.88 CASP1 (0.50) CASP3CASP6CASP8MMEACE
SCHEMBL6631460 0.80 CASP1 (0.48) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6629124 0.77 CASP3 (0.48) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6629120 0.77 CASP3 (0.48) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6627306 0.76 LCK (0.48) MMEACELCKCASP1
SCHEMBL6627304 0.76 LCK (0.48) MMEACELCKCASP1
SCHEMBL6629773 0.75 CASP1 (0.44) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6676663 0.75 CASP1 (0.43) CASP3CASP6CASP8RAB9AMEN1
SCHEMBL6627545 0.75 LCK (0.47) MMEACELCKCAPN1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246824-B1 CARBOXAMIDE DIAZEPIN DERIVATIVES, PREPARATION METHOD, USE AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AVENTIS PHARMA SA (FR) 2004-06-09 EP claimed